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Abstract
Purpose: To identify a minimum list of metrics of international relevance to pub-
lic health, research and service development which can be extracted from practice
management systems and electronic patient records in primary optometric
practice.
Methods: A two stage modified Delphi technique was used. Stage 1 categorised
metrics that may be recorded as being part of a primary eye examination by their
importance to research using the results from a previous survey of 40 vision
science and public health academics. Delphi stage 2 then gauged the opinion of a
panel of seven vision science academics and achieved consensus on contentious
metrics and methods of grading/classification.
Results: A consensus regarding inclusion and response categories was achieved
for nearly all metrics. A recommendation was made of 53 metrics which would
be appropriate in a minimum data set.
Conclusions: This minimum data set should be easily integrated into clinical
practice yet allow vital data to be collected internationally from primary care
optometry. It should not be mistaken for a clinical guideline and should not add
workload to the optometrist. A pilot study incorporating an additional Delphi
stage prior to implementation is advisable to refine some response categories.
Introduction
Accessing data from primary care services is essential for
judging such things as population health and care needs,
service uptake, patient outcomes and performance of ser-
vices. Slade et al.1 highlighted the present inaccessibility of
these data from primary care optometry and identified an
international requirement for a minimum dataset (MDS).
A MDS is a recommendation for standardised minimum
set of metrics to be collected along with the method of col-
lection in order to allow aggregated use of data. An opto-
metric MDS would allow audit and benchmarking, as has
been performed for some time within other areas of pri-
mary and secondary care, for example nursing and inten-
sive care.2,3
Metrics to be recorded within a MDS must be clinically
relevant, otherwise clinicians are unlikely to record the data
consistently and reliably. However, the format in which a
metric is recorded is also of importance in order that it has
validity for both the clinician who records and utilises it
within their practice and for the MDS user (e.g. Researchers
and public health professionals) who wishes to process and
analyse these data. Forced choice options are generally
easier to analyse than free text although from a clinician’s
perspective it is important that the options are comprehen-
sive and the information is easy to record with as few
‘clicks’ as possible. If there are various notations or systems
for recording clinical findings (e.g. visual acuity, tonometry
or fields), the MDS should at least note what approach,
equipment etc. has been used for recoding a metric. The
number of metrics within the MDS is also an issue,
although if data is to be routinely collected by clinicians
anyway, and is easily extractable from practice electronic
patient record software, then this is less of an issue.
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There is no set methodology for the development of a
MDS and a number of approaches have been used.4 In
the present study, a modified Delphi technique5 was
used (Figure 1). The Delphi method was first used by
Dalkey and Helmer in 19636 and is a structured interac-
tive process involving a panel of experts invited to
answer questionnaires in two or more rounds. After
each round, a facilitator provides an anonymous sum-
mary of the experts’ responses to the previous round as
well as the reasons they provided for their judgments.
The experts are encouraged to revise their earlier
responses in light of the replies of other members of
their panel. It is expected that during this process the
range of the answers will decrease and the group will
converge towards a consensus position.
The first stage of the Delphi process used for develop-
ing a primary care optometry MDS was reported by
Slade et al.1 Stage 1 incorporated consultation with three
separate groups, rather than use a single panel of
experts:
(1) Potential users of the MDS (e.g. Researchers and pub-
lic health professionals);
(2) Clinicians working within primary care optometry;
(3) Providers of practice management and electronic
patient record software.
Slade et al.1 reported how potential MDS users scored
80 metrics in terms of importance to research and public
health on a scale of 1–10. The clinicians working within
primary care optometry were asked whether they currently
use computer systems within their practice and for which
purposes. Just over half of primary care optometric prac-
tices now use electronic patient records (EPR, 55%1) as
opposed to paper records with this proportion appearing
to be increasing (39% in a 2014 study7). As part of Delphi
round 1, the clinicians were also asked about the format in
Figure 1. Flowchart of the modified Delphi process.
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which they record clinical information. Slade et al.1
reported that software companies would not be a barrier to
eventual implementation of a MDS and identified which
data was already being collected in practice.
This paper reports stage two of the Delphi process and it
is envisaged these results could inform an in-practice pilot
of a MDS possibly incorporating a further Delphi stage.
Methodology
The 80 metrics used by Slade et al.1 were evaluated by the
authors for inclusion in a MDS. This evaluation was pri-
marily based on:
(1) The importance to potential MDS users (median score
of 8 or higher);
(2) Whether it was already routinely recorded electroni-
cally as reported by the clinicians working within pri-
mary care optometry;
(3) The ease of classification/recording of the metric.
On this basis, metrics were classified by the authors as:
(1) Should be included in a MDS: Data items with a
potential MDS user median rank from Delphi stage 1
of 8 or more which were routinely collected and where
there was a consensus on how they could be classified
(30 metrics);
(2) Borderline or contentious. Data items with a median of 8
or more and were routinely collected but where authors
recognised there was variation in grading/classification of
themetric within primary care optometry (31 metrics);
(3) Should not be included in a MDS: Data items with a
potential MDS user median rank of <8 (19 metrics).
There two exceptions (NHS number and entitlement to
benefits) that did not fit into a category and have been con-
sidered separately, for example, a metric deemed of low
importance to potential MDS users but may be mandatory
for payment reasons and therefore routinely collected.
As part of the Delphi stage 1, potential MDS users were
asked whether they would be interested in participating in
Delphi Stage 2 to help further classify borderline metrics. 13
(of 40) agreed and were sent the metrics for consideration.
Stage 2 participants were given the rank of importance
(based on mean score) for all metrics along with the authors’
recommendation of inclusion, exclusion or borderline. They
were instructed to comment on the inclusion/exclusion of
borderline metrics and on a proposed classification/grading
if this was unclear or had multiple possibilities.
Results
The characteristics of respondents in Delphi stage 1 have
been previously described.1 Seven respondents (of the 13
who originally agreed) contributed to the second round of
the Delphi study and all are research active academic staff at
lecturer level or above from UK University Optometry
Departments (see Acknowledgments). All respondents had
an interest in clinical optometric research, however their
publication histories are extensive and diverse covering
public health, epidemiology, electronic patient records, con-
tact lenses, paediatrics, learning disabilities, facial recogni-
tion, therapeutics, binocular vision, driving, visual acuity,
refractive error, glaucoma and macular disease amongst
many others. The proposed MDS, comprising of 53 metrics,
is shown in Table 1 and the metrics that were initially cate-
gorised by the authors for definite inclusion have been high-
lighted. The 23 metrics which have not been included in the
MDS are in Table 2 with those highlighted as being cate-
gorised initially by authors for definite exclusion. The opin-
ions of respondents to Delphi stage 2 have been discussed
below, and generally did not contest the metrics proposed
by the research team for definite inclusion (including pro-
posed classification) or exclusion although where appropri-
ate some of these have been discussed with related metrics.
Patient demographics
There was consensus to include patient date of birth, gen-
der, and ethnicity.
Patient postcode should also be included as it can be
used to locate a patient within a particular health geogra-
phy for commissioning purposes or to calculate other vari-
ables such as deprivation score for the locality where the
patient lives. Restrictions may need to be placed on who
has access to postcode information in order to protect
patient identity.
It may also be appropriate to include a software assigned
ID number in case it is necessary to link the MDS back to
practice held records.
‘NHS number’ and ‘Entitlement for NHS funded services/
appliances’
Both NHS number and entitlement for NHS funded ser-
vices/appliances metrics were deemed of low importance
(median priority score of 5 and 6 respectively) to the poten-
tial MDS users in the initial Delphi round. These are UK
specific metrics however international equivalents would
replace them where appropriate, for example Medicare num-
ber in Canada or Social security number in the USA.
NHS number is a unique identifier, easily collected, easily
validated and is required by the NHS for many other ser-
vices, thus despite the low median ranking in Delphi stage
1, it is proposed to include it within the MDS. Validation is
a method of ensuring the integrity of a metric by checking
it complies to certain rules or matches with a database and
although possibly not widely known in Optometry, there
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Table 1. Final recommendation of metrics and response categories to be included in a minimum dataset for primary eye care
Metric Response format Response Categories and notes
Patient Demographics
Date of birth† Date Day/Month/Year
Date of clinical episode† Date Day/Month/Year
Gender† Forced choice Male/Female/Other/Rather not say
Ethnicity† Forced choice Office of National Statistics groupings
Postcode† Validated text Standardised format
Software assigned ID number† Software generated
Entitlement to benefits† Forced choice GOS Groupings
National Health Service number† Validated text Standardised format
Occupation Free text
Ocular History and Symptoms
Duration of existing eye
conditions†
Number Days, weeks, months and years (for each eye condition)
Which eye (or surrounding area)
presents with the symptoms†
Forced choice & free text Right/Left/Both/Other
Reason for presenting for an
eye exam
Select all that apply & free text Routine/Reminder. Follow up appointment. New correction
required. New frame required. Blurred near vision. Blurred distance
vision. Headache. Eye pain. Eye strain/discomfort. Red eye. Doctor
advised test. Double vision. Floaters. Visual disturbance. Flashes.
Visual distortion. Eyelid lump/redness/swelling. Dry eye. Facial/lid
spasm. Abnormal lid position. Proptosis. Anisocoria. Other
If they have any existing
eye conditions at presentation
Select all that apply & free text Full ICD-10, using drop-down lists
Current or previous treatment
for eye pathology
Select all that apply with free text &
treatment dates for each selection
None. Surgery. Medication (then full BNF using drop downs).
Ophthalmic review. Orthoptic treatment/exercises. Other
General Health
Name of any existing
systemic conditions
Select all that apply & free text Full ICD-10, using drop-down menus
Current medications for
systemic conditions
Select all that apply & free text Full BNF, using drop down menus
Lifestyle Choices
Whether or not the patient
is a smoker†
Forced choice & date Current/Ex/Never From (date); to (date)
Whether or not the patient
is a driver†
Forced choice Yes/No
Family History
Family history of glaucoma Select all that apply & free text Mother. Father. Sibling. Son/Daughter. Other
Family history of Age
Related Macular Degeneration
Select all that apply & free text Mother. Father. Sibling. Other
Family history of other eye disease Select all that apply, with full ICD-10
using drop-down menus & free text
Mother. Father. Sibling. Son/Daughter. Other
Family history of diabetes Select all that apply & free text Mother. Father. Sibling. Son/Daughter. Other. Ability to specify
type.
Current Refraction Details
Monocular visual acuity with
current spectacles for each eye†
Validated number Distance & near. Notation required (e.g. LogMAR/Snellen)
Current spectacle prescription/
refraction details†
Validated number Sphere/Cylinder/Axis/Add
Monocular unaided vision for
each eye†
Validated number Distance & near. Notation required (e.g. LogMAR/Snellen)
Binocular visual acuity with
current spectacles†
Validated number Distance & near. Notation required (e.g. LogMAR/Snellen)
Binocular unaided vision† Validated number Distance & near. Notation required (e.g. LogMAR/Snellen)
Type of spectacles worn† Select all that apply & free text Single vision distance. Single vision near. Single vision intermediate.
Bifocal. Progressive addition lens. Business/vocational.
(continued)
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are look-up systems for NHS number that could be used. It
is highly likely that NHS number will be required for fund-
ing of future services,8,9 perhaps with the introduction of
electronic submission of claim forms for General Oph-
thalmic Services (GOS).
It is also proposed to include eligibility criteria for NHS
funded services or appliances, as this is also likely to be
extracted as part of the NHS payments system for GOS ser-
vices/appliances and hence collection will be of limited bur-
den for the practice,10 All residents of Scotland are eligible
Table 1 (continued)
Metric Response format Response Categories and notes
Current contact lens specification Free text
Validated number
Forced choice
Forced choice
Number
Fully validated specification not possible.
Sphere/Cylinder/Axis/Add
Modality: Daily disposable/Daily removal/Extended
Material: RGP/Soft/Silicon Hydrogel
Disposal: Days/weeks/months
Clinical Test Results
Distance visual acuity† Validated number With refraction result. Notation required (e.g. LogMAR/Snellen)
Refraction result† Validated number Sphere/Cylinder/Axis/Add
Near visual acuity† Validated number With refraction result. Notation required (e.g. LogMAR/Snellen)
Tonometry† Number (IOP, up to 4 per eye) Forced
choice (method of tonometry). Time.
Method of tonometry: Goldmann applanation tonometry. Other
applanation/contact tonometry. Non-contact tonometry. Rebound
tonometry. Other. 24 h clock; h/min.
Method of fundus examination† Select all that apply & free text Dilated. Undilated. Direct. Slit lamp indirect (e.g. Volk). Headband
indirect. Retinal camera. Widefield Scanning Laser
Ophthalmoscope. Other
Ophthalmic drugs used in
examination (e.g.mydriatic)†
Select all that apply & free text Full Optometrists formulary using drops downs
Visual Fields Forced choice & free text Normal. Suspicious. Pathological defect. Unreliable
Colour vision Forced choice & free text Protanomaly. Deuteranomaly. Unspecified red/green. Tritanomaly.
Acquired (specify). Normal. Other. Test type (free text)
Stereopsis Number & free text Seconds of arc
Test type (free text)
Amsler Select all that apply & free text Normal. Distortion (metamorphopsia). Missing lines (scotoma)
Binocular vision assessment Forced choice & free text Orthophoria. Compensated heterophoria. Decompensated
heterophoria. Heterotropia
Motility Forced choice & free text Normal. Limited. Incomitant
Pupil reactions Forced choice & free text Normal. Abnormal
Clinical signs found in anterior
eye examination
Select all that apply & free text Full ICD-10, using drop-down menus
Clinical signs found in internal
examination
Select all that apply & free text Crystalline lens. Vitreous. Optic disc. Retinal blood vessels. Retina.
Macula
Examination Outcomes
If the patient was referred† Forced choice Yes/No
How urgently the patient
was referred†
Number Days, weeks, months
Who the patient was referred to† Select all that apply & free text GP/Hospital/Optometrist/Social Services/Other
Why the patient was referred Select all that apply & free text Full ICD-10, using drop-down menus
Whether there was a clinically
significant change in refraction
Forced choice Yes/No
Whether spectacles/contact
lenses were prescribed†
Select all that apply & free text Spectacles/Contact lenses/Other
How much refraction
has changed†
Validated Number From prescription metrics
Purpose for which spectacles/
contact lenses were prescribed†
Select all that apply & free text Distance/Near/Bifocal/Progressive/Other
Recommended recall date for
the next eye examination†
Validated number Months/Years
GOS, General Ophthalmic Services. ICD-10, International Classification of Diseases 10. BNF, British National Formulary.
†Metrics that were initially recommended to Delphi stage 2 respondents for inclusion by the authors based on the results from Slade et al.1 and having
a grading/classification scale that was not contentious.
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for NHS funded eye examinations, but eligibility criteria
still apply for funding towards optical appliances. Informa-
tion about receipt of means tested State benefits will also
provide another indicator of socioeconomic status, and
medical/family history of glaucoma, diabetes etc. may also
have some utility for public health purposes.
Occupation
The UK Office for National Statistics Socio-economic classi-
fications11 were proposed to Delphi stage 2 respondents as
these are widely used for public health purposes. However
the information of importance to the potential MDS users
may be at odds to that which is of importance to the clini-
cian. One Delphi stage 2 respondent suggested alternative
categories of ‘pre-school’, ‘student’, ‘unemployed’, ‘admin-
istration’, ‘manual’, ‘vehicle operator’ and ‘retired’, however
this does not address the concerns of the other respondents
that if the categories are not clinically relevant then
recording will be poor and these data will be unreliable.
Some Delphi stage 2 respondents appreciated forced choice
for simplifying analysis, but if there is not a categorisation
equally valid for both researcher and clinician then free text
is the most reliable format allowing later classification with
predefined protocols. In any case, it is proposed to include
postcode within the MDS, and hence it would be possible to
use this to derive deprivation scores for the postcode in
which the patient lives, and hence provide a proxy for the
socioeconomic status of the patients themselves.
History and symptoms
‘Reason for presenting for an eye exam’ and ‘details of any
symptoms experienced’
Within Delphi stage 1, these metrics were both of impor-
tance and routinely collected but the authors were mainly
concerned with the appropriateness of the response format
and completeness of the categories. The Delphi stage 2
respondents suggested that they could be combined and
redefined in terms of ‘primary reason for presenting’. Con-
sensus was unanimous in support of a format that encour-
aged clinicians to ‘select all that apply’ with the option of
an additional free text response. The Delphi stage 2 respon-
dents were also broadly in favour of the response cate-
gories, however additional categories were suggested to
assist differential diagnosis12,13 and avoid lost data for epi-
demiological research. The additional categories were: ‘fol-
low up appointment’, ‘new correction required’, separation
of ‘distance’ from ‘near’ blur and separation of ‘discomfort’
from ‘pain’. One Delphi stage 2 respondent felt that ‘symp-
toms/routine/other’ would equally suffice.
Existing eye conditions at presentation
The Delphi stage 2 consensus was strongly in favour of
keeping this metric and using the World Health Organisa-
tion International Classification of Diseases Version 10
(ICD-10).14 ICD-10 is a medical classification system for
diseases, signs and symptoms, abnormal findings, com-
plaints, social circumstances, and external causes of injury
or diseases. Related pathologies are grouped into blocks,
for example H43-H45 contains the codes for ‘disorders of
vitreous body and globe’. Depending on certainty and
specificity of the diagnosis, a clinician could record a diag-
nosis of asteroid hyalosis at this block level, or as H43 for
disorders of vitreous body or H43.2 for ‘crystalline deposits
in vitreous body’ after a maximum of three clicks14 without
having to remember that the code is H43.2. In the case of a
disease sub-classification (e.g. Wet v Dry AMD) not being
present in ICD-1015 the free text could supplement it.
The duration of any existing eye conditions and which
eye (or surrounding area) is affected by symptoms should
also be recorded.
Table 2. Metrics not included in a minimum dataset This could be due
to lack of importance to research and public health (based on the results
from Slade et al.1 and consensus in the present study) or due to diffi-
culty in classifying/grading the metric.
Patient Demographics
Other aspects related to patient demographics†
Patient name†
Ocular History and Symptoms
Any other data related to eye health†
General Health
Previous treatment for systemic conditions
Planned future treatment for systemic conditions (e.g. surgery)†
Other aspects related to general health†
Lifestyle Choices
How long the patient has been a smoker†
If the patient has given up smoking how long ago it was†
Whether the patient drinks alcohol
The amount of alcohol that is drunk†
What sort of hobbies or interests the patient has†
If the patient has given up alcohol†
Other aspects relating to patient lifestyle†
Family History
Family history of other eye conditions†
Family history of other systemic disease†
Family history of spectacle/contact lens wear†
Other aspects related to family history†
Current Refraction Details
Purpose for which spectacles worn
Whether spectacles are worn full time or only for specific purposes†
Any other aspects related to refraction and spectacles/contact lenses†
Clinical Test Results
Clinical signs found in surrounding eye area
Results of any other clinical tests†
Examination Outcomes
Any other information about the advice given to the patient†
†Metrics that were initially recommended to Delphi stage 2 respondents
for exclusion by the authors based on the results from Slade et al.1
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Current or previous treatment for existing eye and systemic
conditions
These metrics were judged to be of importance to potential
MDS users in Delphi stage 1, however, classification of the
type of treatment is challenging. The Delphi stage 2 respon-
dents agreed further classification for type of surgery may
be too complicated or time consuming. ‘Current’ and ‘pre-
vious treatment’ were initially separate but a number of
Delphi stage 2 respondents expressed concern over the
specificity of terms such as ‘impending’, ‘recent’, ‘current’
and ‘previous’ and recommended that these could be
replaced by the approximate dates of treatment as recalled
by the patient. The additional response category ‘orthoptic
treatment/exercises’ was also suggested.
Use of a national formulary, for example the British
National Formulary (BNF) was strongly supported by
respondents, and similar to the ICD-10, intelligent use of
drop-down menus should allow clinicians to be as specific
as they want to be, but still be of use if patients cannot recall
the exact drugs they are taking. For example, with one click
the clinician can specify what the drug is treating (e.g. glau-
coma), with one more click the class of drug (e.g. prosta-
glandin analogue), or with an extra click the exact drug (e.g.
Latanoprost). One Delphi stage 2 respondent also identified
‘previous treatment for systemic conditions’ as being some-
times important clinically, however, the majority view was
that it was superfluous to a primary care optometry MDS.
Lifestyle choices
There are a number of metrics relating to smoking, the sim-
plest being whether the patient smokes or not, which was
desired in Delphi stage 1 by potential MDS users and also
routinely collected and therefore included in the MDS.
Inclusion of further information about duration or amount
of smoking divided opinion within Delphi stage 2. ‘How
much the patient smokes’ was thought to be impossible to
accurately quantify and therefore unreliable. Historically it
was appropriate to ask patients how many cigarettes they
smoked per day, however ‘roll your own’ tobacco is becom-
ing more popular and now accounts for one in three smok-
ers.16 Two Delphi stage 2 respondents stated it was
important to identify previous smokers, which could be
implemented simply by including ‘to’ and ‘from’ dates
alongside the smoking question already included in the
MDS.
Although reported as important during Delphi stage 1,
alcohol consumption was identified as being of low impor-
tance clinically. Therefore results are likely to be unreliable
and it should not be included.
It was also deemed appropriate to record whether or not
the patient drives a vehicle, as this may be more valid than
whether they hold a driving licence.
Family history
Glaucoma, AMD, cataract, genetic eye disease, diabetes and
heart disease were considered separately. Clinical geneticists
record family history via a full pedigree but this is not real-
istic in primary care optometry. The Delphi stage 2 consen-
sus was strongly in favour of discarding metrics for family
history of cataract or heart disease due to the number of
other risk factors and the difficulty in quantifying risk. This
would not preclude clinicians recording cataract family his-
tory if deemed appropriate. Family history of glaucoma was
judged as the most important inheritance risk factor to
potential MDS users and all direct relatives have been
included as they have different risk ratios17 apart from
mother/father.
Parent gender has been separated as it adds no additional
workload to the clinician (the patient normally specifies
which parent without prompting) and it may be of rele-
vance to other familial conditions which allows the
response categories to be consistent for AMD and genetic
eye disease. Consensus was strongly in favour of these cate-
gories without ‘son/daughter’ for AMD due to the age-
related incidence. Respondents were in favour of including
‘genetic eye disease’ but identified that patients won’t know
which eye conditions are genetic hence it could be renamed
‘other eye conditions’ which then allows the clinician to
select the disease from ICD-10 if in their clinical opinion
they feel it is relevant. Ability to specify type of diabetes was
also of importance.
Current refraction details
Current contact lens specification
This metric was deemed as important to potential MDS
users and clinicians in Delphi stage 1, and a full validated
specification including manufacturer/design would be of
value, for example within case control investigations of
contaminated products. However, most Delphi stage 2
respondents acknowledged that this may be impractical
due to the variety of different manufacturers, designs and
materials and the speed with which lenses get released or
rebranded would make producing a standard validation
database very difficult. A Delphi stage 2 consensus was not
obtained and the majority of respondents remained unde-
cided, although the easily categorised elements of the met-
ric could be included, for example wear modality,
frequency of replacement, type of material, prescription.
Purpose for which spectacles worn
This metric was wanted by Delphi stage 1 potential MDS
users and is usually collected in practice, however, all but
one respondent in stage 2 wanted to discard this metric.
Due to the potentially wide, complex and personal range of
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uses it may be very difficult to categorise therefore the
results could be meaningless.
Clinical test results
Visual fields
Although of definite interest to Delphi stage 1 potential
MDS users, this is perhaps the most difficult metric as there
is no single way of recording visual field impairment to
adequately classify the results. Some methods have been
suggested, but tend to be specific to certain automated field
assessment machines (e.g. Hodapp et al.18 for the Hum-
phrey Visual Field Analyser; www.zeiss.com) of which there
are a diverse selection in use in primary care optometry,
and a range of different testing strategies on each.
Responses in Delphi stage 2 were split, with the majority
preferring a simple classification system (Normal. Suspi-
cious. Pathological defect. Unreliable) as a way of covering
all potential defects albeit losing some detail. One Delphi
stage 2 respondent suggested discarding this metric due to
the difficulty in classification and hence giving unreliable
data. One stage 2 respondent suggested a more complex
classification system retaining better diagnostic informa-
tion. Subjectivity of ‘physiological defect’ meant that this
category should be not be used.
Colour vision
In addition to recording the specific colour vision
abnormality, the MDS could include details of the type
and manufacturer of colour vision test, which, alongside
the version of the test, the age or condition of the test
and the often non-standardised testing conditions could
lead to huge variability in the quality of data collected.
These reasons resulted in two Delphi stage 2 respondents
suggesting discarding the metric. The remainder agreed
on the inclusion of a simple classification system
(Table 1) without the test type/manufacturer, although
one respondent suggested the more comprehensive grad-
ing system from ICD-10 which may suffer from a lack
of validity due to the aforementioned variability in
recording. Given clinicians may record type/manufac-
turer of test anyway it is expected they will utilise the
additional free text to specify this along with other rele-
vant clinical details. The content of this field following a
pilot and further Delphi stage would help to inform
whether test type should be included in a subsequent
version of the proposed MDS.
Stereopsis
Opinion in Delphi stage 2 was split on whether to record
the type of test used to assess stereopsis, with three respon-
dents wanting to retain the metric and format, one with no
view, and three wanting to discard due to the large
variability of testing meaning reduced validity. Similarly to
‘Colour vision’ it is therefore proposed to retain the facility
to record test type as free text, and the results from a pilot
study would help to refine this.
Amsler
Clinicians often sketch, or ask the patient to sketch, any
defects found on Amsler when using paper records to illus-
trate both location and size which is difficult to capture as
part of a MDS. Two Delphi stage 2 respondents chose to
omit this metric however the majority agreed on inclusion.
One respondent identified an improvement would be a ‘se-
lect all that apply’ response format and would be most
appropriate in case patients report both distortion and
missing lines.
Binocular vision assessment
This was an important metric to Delphi stage 1 potential
MDS users, however a binocular vision assessment can vary
greatly in its content. The majority of the stage 2 respon-
dents regarded simple response options of abnormal/suspi-
cious/normal as invalid due to their gross subjectivity and
one rejected the metric entirely for this reason. There was
broad consensus in Delphi stage 2 of a less subjective classi-
fication (Table 1) however these data should still be
approached with caution. Deviation was not included as
even under experimental conditions inter-examiner
repeatability is poor.19
Motility
Subjectivity renders an abnormal/suspicious/normal system
invalid, however the majority of Delphi stage 2 respondents
felt it should still be included with alternative categories
(Table 1). It would be unrealistic to isolate and document
the muscle/nerve of underaction in all cases.
Pupil reactions
Those Delphi stage 2 respondents with an opinion uni-
formly felt it should still be included, with one suggesting a
more comprehensive classification and the remainder
agreeing with a binary abnormal/normal system with an
additional free text box. Potential MDS users using this
metric would likely categorise the free text according to
their needs.
Clinical signs found in surrounding eye area
(e.g. pigmentation)
All but one respondent suggested exclusion of this metric
due to low importance in Delphi stage 1, burden on the
clinician and ambiguity of metric. These data are routinely
recorded in primary care and are potentially clinically valu-
able; however the above reasons would invalidate these data
for research and public health purposes.
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Clinical signs found in anterior eye examination
Although clinically essential, this metric is very difficult to
classify due to the large variety of tissues and pathologies it
covers. The consensus was that these data should be
included but an abnormal/suspicious/normal system is too
simple. There are various grading systems that could be
incorporated here, and Delphi stage 2 respondents who
gave an opinion suggested the ICD-10. However this may
lose data when a clinician detects a suspicious abnormality
but is not certain of the diagnosis (e.g. uncertain whether a
lesion is malignant or not). In combination with the free
text box, ICD-10 is probably the most comprehensive solu-
tion that can be compatible with research but it must be
stressed that this is merely for the purpose of a MDS, and
there are much more comprehensive recording mecha-
nisms to be used in tandem to enhance the clinical record.
Clinical signs found in internal examination (e.g. lens haze,
disc appearance, macula appearance)
There is a difficulty of classification with such a wide vari-
ety of normal and abnormal findings. There is also overlap
with metrics deemed more important (e.g. ‘why the patient
was referred’). Consensus in Delphi stage 2 was for inclu-
sion and respondents felt this metric should be divided by
ocular structure (Table 1). There are various published
grading scales that could then potentially be used to sub
classify variation and abnormalities of each structure (e.g.
lens20,21) however further work including a literature
review would be required to determine the most appropri-
ate for primary care optometry.
Examination outcomes
Whether refraction has changed
This metric is also on the GOS1 claim form for NHS
funded sight tests and is a clinical decision rather than a
numerical difference in prescription which could be
obtained from the prescription metrics, especially if it is
possible to link the results of sight tests via the NHS
number. However one respondent highlighted that this is
dependent on the repeatability of refraction.22 In order to
emphasize this metric as a clinical decision a suggestion
was to rename the metric ‘whether there was a clinically
significant change in refraction’. The majority of Delphi
stage 2 respondents, with an opinion, were in support of
inclusion.
Discussion
While this paper describes a proposed MDS, a pilot study
incorporating a Delphi stage 3 will assist with further refin-
ing of which metrics should be included or excluded and
how the included metrics should be classified and recorded.
Analysis of free text box usage should be particularly infor-
mative.
The optical professionals may need to change the way
that clinical information is documented, for example with
drop down boxes rather than free text, or starting to docu-
ment tests such as visual fields in one of a more limited
range of ways. However, it is important to note that just
because there is a data field within the MDS, this does not
mean that it has to be completed. For example, including a
metric for stereopsis does not mean that this needs to be
measured for all patients, only that if an optometrist deems
that assessing stereopsis is appropriate for a particular
patient, then the findings should be recorded. However,
this is no different to existing professional good practice on
record keeping.23
Further development of the MDS will face challenges that
are; political, professional, financial and technical. The
optical sector may see the MDS as yet another addition to
their workload without financial recompense. Thus, there
is a danger that negotiations about the implementation of
the MDS get caught up with other negotiations around fees
and payments associated with the GOS contract. Key to
successful compliance with the MDS will be demonstration
that the MDS does not require much or any additional data
to that already collected. Indeed, if the MDS is associated
with automated capture of activity under a GOS contract
and electronic patient referral to secondary care, then there
might actually be long term cost and time savings for the
optical sector.
In order to capture data for the MDS it is likely that soft-
ware used in primary care optometry will need to be
updated to be MDS compliant. The software manufacturers
do not see this as an issue if that is what is required by their
customers.1 However, it is unreasonable to expect a practice
to change software that is otherwise suited to their needs,
with the accompanying costs and training requirements.
Slade et al.1 reported that 10% of practices do not currently
use a computer. Of those who do use a computer 45% do
use it for electronic patient records. The reasons for not
using electronic records included: ‘content with established
paper system’, 49%; ‘too difficult to change from paper to
computer records’, 28%; ‘no computer in consulting room’,
22%; ‘cost of software’, 20%; ‘low IT knowledge’, 12%; ‘cost
of hardware’, 9%. Thus, financial investment will be
required to facilitate practices being ‘MDS ready’.
There will be technical challenges of ensuring that data
can be extracted from practice systems in a reliable and safe
way for example there are privacy and ethical issues in shar-
ing some of these data without the correct level of
anonymisation. The NHS N3 private network (www.n3.
nhs.uk) has been designed for the use of NHS trusts and
other appropriate stakeholders to allow secure transfer of
potentially sensitive patient data. GP practices are required
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to have an N3 connection. However, dental information is
input to a central web-based solution using standard inter-
net. Ultimately, a decision would need to be made regard-
ing risk and the sensitivity of the data being transferred to
determine the most suitable electronic solution for data
transfer and storage.
Although a consensus Delphi approach was used to
develop the proposed MDS, the third stage of the Delphi
process is yet to be performed and further consultation will
be required with clinicians who would provide data and
potential users of the MDS. Piloting will be required of pro-
posed option choices within the metrics to assess whether
they are fit for purpose both clinically and for research/pub-
lic health purposes. Although forced choice has been used
where possible to allow clean data, free text boxes (and other
mechanisms) are essential from a clinical perspective. Free
text data will help refine the MDS over time by identifying
missing response categories. Software engineers will then
need to incorporate the MDS into existing user-friendly
clinical interfaces. Some metrics, for example visual acuity,
would require the practice to select their preferred notation,
for example Snellen. When subsequently analysed for
research purposes conversion will be possible (in this exam-
ple to LogMAR as that is the gold standard for research),
albeit not ideal.24,25 Further development may involve opin-
ion from a specialist questionnaire designer and optometrist
focus groups to identify ambiguous, poorly worded or miss-
ing response categories from a clinical perspective.
The views of patients should also be incorporated,
although many patients already assume that data is shared
within the NHS in order to facilitate improvements in
quality of care. There will nonetheless be ethical and legal
data protection issues which require further consideration.
Ethical aspects of using anonymous patient data for pub-
lic health purposes need to be considered26 alongside issues
of holding patient identifiable data (PID). Postcodes may
be required for service planning, however may not be
required for research purposes as these data could be con-
verted prior to use, for example Deprivation or socioeco-
nomic groupings.27
It must be stressed once again that this is a MDS
designed to allow ease of input and therefore result in valid
data extraction. It is not a clinical guideline and should not
put onus on the profession in this regard, for example,
‘Unaided distance visual acuity’ is in the MDS however
may not be routinely collected for high myopes as it is of
little clinical value. It is concerning whether data collected
in this way would be reliable enough for research purposes
due to the lack of standardisation of clinical practice, how-
ever epidemiological data in other professions are collected
in similar ways. As the MDS is implemented, or as part of a
pilot, these data would need validating so their reliability
can be established.
Limitations
While the Delphi technique is a recognised tool for devel-
oping consensus positions it does have a number of weak-
nesses. Due to the iterative process that is integral to the
Delphi process, there exists the potential for low response
rates if people drop out after each round. Fourteen aca-
demics originally agreed to participate in stage 2 and were
sent the metrics, but only seven (54%) finally responded.
Whilst seven potential MDS users may seem a small num-
ber to include within Delphi stage 2, this is in keeping with
other studies that have used the Delphi technique to
develop a minimum dataset. For example Bagley-Thomp-
son and Schaffer5 had eight respondents within their sec-
ond Delphi round. Potential concerns about the final
proposed MDS being biased by small numbers could be
ameliorated by inviting all the individuals who responded
to stage 1 to participate in a further Delphi stage as part of
a pilot study. The fact that that the Delphi technique is iter-
ative and sequential also means that it can be time-consum-
ing and laborious, as it is necessary to give sufficient time
for panel members to consider their own position and to
reflect on the views of other panel members. The fact that
panel members do this process in isolation from one
another also means that there is a risk of the facilitators
moulding opinions if they (un)intentionally give more
weight to one perspective than another. The process of pro-
ducing summary documents to be considered in subse-
quent rounds, is however, more than just providing a
statistical report of ‘how many people said what’ as it is
necessary to recognise that panel members have differing
expertise and a minority of respondents may identify an
issue that is missed by the majority.
There are still issues with some important metrics which
have been highlighted in the results as requiring further
reflection: Occupation, Clinical signs found in internal
examination, Visual fields and Contact lens specification. It
is not possible to comprehensively gather all the clinical
information in these instances which limits the usefulness of
the MDS, however this will be outweighed in part by the
large size of the datasets. The inclusion of free text boxes will
allow development of the MDS and refinement of these met-
rics in future. Some metrics may be more difficult to classify
than they first appear, for example, gender. The sex assigned
at birth may be more clinically relevant due to risk factors,
however this may not be what the patient identifies as.
Conclusions
This MDS should be easily integrated into clinical practice
yet allow essential data to be collected internationally from
primary eye care. These data are currently inaccessible yet
vital for judging such things as population health and care
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needs, service uptake, patient outcomes and performance
of services. It should not be mistaken for a clinical guideline
and should not add workload to the optometrist. A pilot
study incorporating an additional Delphi stage prior to
implementation is advisable to refine some response cate-
gories and as a demonstration of the breadth of research
questions which could be answered.
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